EUVIMEDEUVIMED entdecken
Crossref

A multiple-responsive nano-prodrug combining chemo-differentiation–cancer stem cell inhibition toward triple-negative breast cancer

Yanting Li, Mengdan Ning, Haoping Long, Jiayi Zuo, Jinqiu Liang, Ting Yuan, Feng Cao, Yong Yin, Feng Jiang

Biomaterials Science · 2026

DOI: 10.1039/d5bm01254f ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomaterials Science, 2026. Verfasst von Yanting Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 210009, PR China. jiangfeng@cpu.edu.cn. Hauptthemen laut MEDLINE: Prodrugs, Neoplastic Stem Cells, Triple Negative Breast Neoplasms, Nanoparticles. Die Arbeit nennt 83 Literaturangaben. Gefördert von: Natural Science Foundation of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Multi-stimuli-responsive nanoprodrug implementing a “chemo-differentiation–cancer stem cell inhibition” strategy toward triple-negative breast cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsNeoplastic Stem CellsTriple Negative Breast NeoplasmsNanoparticlesTretinoinAntineoplastic AgentsHumansFemaleAnimalsMDA-MB-231 CellsIrinotecanMiceCell DifferentiationCell Line, TumorApoptosis

Substanzen

ProdrugsTretinoinAntineoplastic AgentsIrinotecan

Autor:innen und Institutionen

  • Department of Pharmaceutical Engineering, School of Engineering, China Pharmaceutical University, Nanjing, 210009, PR China. jiangfeng@cpu.edu.cn.
  • Jiangsu Key Laboratory of Bioactive Natural Product Research and State Key Laboratory of Natural Medicines, School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing 210009, PR China. yongyin@cpu.…
  • Department of Pharmaceutical, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, PR China. cpufengc@cpu.edu.cn.

Förderung

  • Natural Science Foundation of Jiangsu Province

Zitieren

APA

Li, Y., Ning, M., Long, H., Zuo, J., Liang, J., Yuan, T., Cao, F., Yin, Y., & Jiang, F. (2026). A multiple-responsive nano-prodrug combining chemo-differentiation–cancer stem cell inhibition toward triple-negative breast cancer. Biomaterials Science. https://doi.org/10.1039/d5bm01254f

Vancouver

Li Y, Ning M, Long H, Zuo J, Liang J, Yuan T, et al. A multiple-responsive nano-prodrug combining chemo-differentiation–cancer stem cell inhibition toward triple-negative breast cancer. Biomaterials Science. 2026. doi:10.1039/d5bm01254f

BibTeX
@article{Li2026,
  author = {Li, Yanting and Ning, Mengdan and Long, Haoping and Zuo, Jiayi and Liang, Jinqiu and Yuan, Ting and Cao, Feng and Yin, Yong and Jiang, Feng},
  title = {A multiple-responsive nano-prodrug combining chemo-differentiation–cancer stem cell inhibition toward triple-negative breast cancer},
  journal = {Biomaterials Science},
  year = {2026},
  doi = {10.1039/d5bm01254f}
}
Kostenlos starten →